I agree that this site is using cookies. You can find further informations here.
X
Frohling, Felix
57  results:
Search for persons X
?
1

Bewertung der Umweltbilanzen von Materialien im deutschen G..:

Rheude, Felix Volker , 2024
Link: https://nbn-resolving.or..
 
?
2

Design of an Experiment to Pinpoint Cognitive Failure Proce..:

, In: 2023 IEEE Intelligent Vehicles Symposium (IV),
Denk, Florian ; Frohling, Felix ; Brunner, Pascal... - p. 1-8 , 2023
Link: https://doi.org/10.1109/..
 
?
3

Total Error Sheets for Datasets (TES-D) zur Dokumentation D..:

Fröhling, Leon ; Sen, Indira ; Soldner, Felix...
doi:10.5281/zenodo.8341605.  , 2023
Link: https://zenodo.org/recor..
 
?
4

Total Error Sheets for Datasets (TES-D) -- A Critical Guide..:

Fröhling, Leon ; Sen, Indira ; Soldner, Felix...
http://arxiv.org/abs/2306.14219.  , 2023
Link: http://arxiv.org/abs/230..
 
?
5

RELB activation drives tumour aggressiveness and predicts p..:

Nader, Luisa ; Nichetti, Federico ; Scherr, Anna-Lena...
Journal of Hepatology.  77 (2022)  - p. S655-S656 , 2022
Link: https://doi.org/10.1016/..
 
?
6

Molecular matched targeted therapies for primary brain tumo..:

Luger, Anna-Luisa ; König, Sven ; Samp, Patrick Felix...
Journal of Neuro-Oncology.  159 (2022)  2 - p. 243-259 , 2022
Link: https://doi.org/10.1007/..
 
?
7

MGMT inactivation as a new biomarker in patients with advan..:

Niger, Monica ; Nichetti, Federico ; Casadei‐Gardini, Andrea...
Molecular Oncology.  16 (2022)  14 - p. 2733-2746 , 2022
Link: https://doi.org/10.1002/..
 
?
8

Molecular matched targeted therapies for primary brain tumo..:

Luger, Anna-Luisa ; König, Sven ; Samp, Patrick Felix...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424147/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
9

Molecular matched targeted therapies for primary brain tumo..:

Luger, Anna-Luisa ; König, Sven ; Samp, Patrick Felix...
http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/69467.  , 2022
Link: http://publikationen.ub...
 
?
10

MGMT inactivation as a new biomarker in patients with advan..:

Niger, Monica ; Nichetti, Federico ; Casadei‐Gardini, Andrea...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297767/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
11

Bcl-x(L) as prognostic marker and potential therapeutic tar..:

Hoffmeister-Wittmann, P. (Paula) ; Mock, A. (Andreas) ; Nichetti, F. (Federico)...
https://hdl.handle.net/10171/65016.  , 2022
Link: https://hdl.handle.net/1..
 
?
12

Histological and molecular plasticity of ALK-positive non-s..:

Ball, Markus ; Christopoulos, Petros ; Kirchner, Martina...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059782/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
13

Molecular matched targeted therapies for primary brain tumo..:

Luger, Anna-Luisa ; König, Sven ; Samp, Patrick Felix...
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/97586.  , 2022
Link: https://opus.bibliothek...
 
?
14

MGMT inactivation as a new biomarker in patients with advan..:

Monica Niger ; Federico Nichetti ; Andrea Casadei‐Gardini...
https://doi.org/10.1002/1878-0261.13256.  , 2022
Link: https://doi.org/10.1002/..
 
?
15

MGMT inactivation as a new biomarker in patients with advan..:

Niger, Monica ; Nichetti, Federico ; Casadei-Gardini, Andrea...
info:eu-repo/semantics/altIdentifier/pmid/35621918.  , 2022
Link: http://hdl.handle.net/24..
 
1-15